WCM Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.69M | Buy |
210,469
+8,256
| +4% | +$302K | 0.02% | 151 |
|
|
2025
Q1 | $7.65M | Buy |
202,213
+66,604
| +49% | +$2.52M | 0.02% | 154 |
|
|
2024
Q4 | $5.73M | Sell |
135,609
-9,740
| -7% | -$412K | 0.01% | 174 |
|
|
2024
Q3 | $7.91M | Sell |
145,349
-9,326
| -6% | -$508K | 0.02% | 156 |
|
|
2024
Q2 | $6.41M | Buy |
154,675
+2,175
| +1% | +$90.1K | 0.02% | 155 |
|
|
2024
Q1 | $7.12M | Buy |
152,500
+31,515
| +26% | +$1.47M | 0.02% | 150 |
|
|
2023
Q4 | $5.84M | Buy |
120,985
+13,220
| +12% | +$638K | 0.02% | 160 |
|
|
2023
Q3 | $3.85M | Buy |
107,765
+2,460
| +2% | +$88K | 0.01% | 161 |
|
|
2023
Q2 | $4.87M | Buy |
105,305
+7,488
| +8% | +$346K | 0.01% | 158 |
|
|
2023
Q1 | $3.92M | Buy |
97,817
+1,047
| +1% | +$42K | 0.01% | 165 |
|
|
2022
Q4 | $4.48M | Buy |
96,770
+6,715
| +7% | +$311K | 0.02% | 163 |
|
|
2022
Q3 | $3.65M | Buy |
90,055
+6,612
| +8% | +$268K | 0.01% | 152 |
|
|
2022
Q2 | $5.03M | Sell |
83,443
-164
| -0.2% | -$9.88K | 0.02% | 148 |
|
|
2022
Q1 | $6.07M | Buy |
83,607
+6,898
| +9% | +$501K | 0.02% | 140 |
|
|
2021
Q4 | $6.45M | Buy |
76,709
+3,297
| +4% | +$277K | 0.01% | 147 |
|
|
2021
Q3 | $6.62M | Buy |
73,412
+506
| +0.7% | +$45.6K | 0.02% | 142 |
|
|
2021
Q2 | $6.95M | Buy |
72,906
+2,841
| +4% | +$271K | 0.02% | 136 |
|
|
2021
Q1 | $7.98M | Sell |
70,065
-1,664
| -2% | -$189K | 0.02% | 122 |
|
|
2020
Q4 | $9.93M | Buy |
71,729
+3,917
| +6% | +$542K | 0.03% | 113 |
|
|
2020
Q3 | $5.57M | Buy |
67,812
+4,166
| +7% | +$342K | 0.02% | 129 |
|
|
2020
Q2 | $4.98M | Buy |
63,646
+2,075
| +3% | +$162K | 0.02% | 130 |
|
|
2020
Q1 | $2.74M | Buy |
+61,571
| New | +$2.74M | 0.02% | 140 |
|